2019
DOI: 10.1080/14767058.2018.1542675
|View full text |Cite
|
Sign up to set email alerts
|

Elevated blood carboxyhemoglobin levels as an early predictor of phototherapy requirement in moderate and late preterm infants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…Schutzman et al 19 found that CO levels did not differ significantly between negative DCT neonates. Varal et al 22 study on middle and late preterm neonates concluded that the initial COHb levels of babies who received phototherapy were significantly higher than those of babies who did not need this treatment, and this difference persisted over consecutive hours. Uetani et al 23 found that COHb levels in neonates with ABO-incompatible hyperbilirubinemia were significantly higher than levels in ABO-compatible neonates with hyperbilirubinemia in term neonates.…”
Section: Discussionmentioning
confidence: 99%
“…Schutzman et al 19 found that CO levels did not differ significantly between negative DCT neonates. Varal et al 22 study on middle and late preterm neonates concluded that the initial COHb levels of babies who received phototherapy were significantly higher than those of babies who did not need this treatment, and this difference persisted over consecutive hours. Uetani et al 23 found that COHb levels in neonates with ABO-incompatible hyperbilirubinemia were significantly higher than levels in ABO-compatible neonates with hyperbilirubinemia in term neonates.…”
Section: Discussionmentioning
confidence: 99%
“…Because COHb is released early as a breakdown product of heme, it is an early predictor of response to phototherapy for hyperbilirubinemia in preterm infants, with a sensitivity of 90% and a specificity of 88%. 34 Whether COHb serves a similar purpose in dogs with immunemediated hemolytic anemia in predicting the need for adjunctive therapy, such as additional blood transfusions, total plasma exchange, or multiple immunosuppressive medications, deserves exploration.…”
Section: Discussionmentioning
confidence: 99%